GLUE
Monte Rosa Therapeutics Inc
12.60$
-0.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Monte Rosa Therapeutics Inc (GLUE) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/08/2026 | Current report (8-K) | Monte Rosa Therapeutics, Inc. (GLUE): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/06/2026 | Current report (8-K) | Monte Rosa Therapeutics, Inc. (GLUE): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.